QR-Code

Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 - data from the Romanian Registry of Rheumatic Diseases

Objective. The objective of this cross-sectional study was to analyze data available in the Romanian Registry of Rheumatic Diseases (RRBR) in 2022 for axial spondyloarthritis (axSpA) patients treated with biologic disease modifying anti-rheumatic drugs (bDMARDs). Methods. From the RRBR electronic da...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Laura Muntean, Razvan Ionescu, Corina Mogosan, Maria-Magdalena Tamas, Claudiu C. Popescu, Elena Rezus, Razvan-Constantin Ionitescu, Ana Maria Ramazan, Andrei Eugen Martin, Catalin Codreanu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Amaltea Medical Publishing House 2023-12-01
Schriftenreihe:Romanian Journal of Rheumatology
Schlagworte:
axial spondyloarthritis
biologics
romanian registry of rheumatic diseases
Online-Zugang:https://rjr.com.ro/articles/2023.4/RJR_2023_4_Art-04.pdf
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge